Anti-B7-H4

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

B7-H4, also known as B7x or B7S1, is a new member of the B7 family of immune co-signaling molecules. Despite the wide distribution in mRNA levels, B7-H4 protein expression is generally absent in peripheral tissues but is increased on many cancer cells or tumor-associated immune cells. In addition, B7-H4 upregulation has shown to be associated with diseases progression and/or outcome in some cancers. The unique expression of B7-H4 in the tumor microenvironment and its potential immune inhibitory functions on both innate and adaptive immune responses represents a novel target for the next-generation cancer diagnosis and immunotherapy.

Cite

CITATION STYLE

APA

Wang, J., & Chen, L. (2017). Anti-B7-H4. In Cancer Therapeutic Targets (Vol. 1–2, pp. 21–29). Springer New York. https://doi.org/10.1007/978-1-4419-0717-2_48

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free